OXADIAZASPIRO COMPOUNDS FOR USE IN THE TREATMENT OF MOTONEURON DEGENERATION OR IN NEUROPROTECTION

The present invention relates to compounds having pharmacological activity towards the sigma () receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.

Saved in:
Bibliographic Details
Main Authors VELA-HERNANDEZ, Jose-Miguel, NAVARRO-ACEBES, Xavier, HERRANDO-GRABULOSA, Mireia, MERLOS-ROCA, Manuel
Format Patent
LanguageEnglish
French
German
Published 31.07.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds having pharmacological activity towards the sigma () receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.
Bibliography:Application Number: EP20220790466